National Coverage Analysis (NCA)

Positron Emission Tomography (FDG) for Solid Tumors

CAG-00181R

Expand All | Collapse All

Contacts

David Dolan
David.Dolan@cms.hhs.gov
410-786-3365
Lead Analysts
Lead Medical Officers

History of Considerations

History Title ID View the document version
Original Consideration Positron Emission Tomography (FDG) for Brain, Cervical, Ovarian, Pancreatic, Small Cell Lung, and Testicular Cancers CAG-00181N View
First reconsideration Positron Emission Tomography (FDG) for Solid Tumors CAG-00181R You are here
Second reconsideration Positron Emission Tomography (FDG) for Cervical Cancer CAG-00181R2 View
Third reconsideration Positron Emission Tomography for Initial Treatment Strategy in Solid Tumors and Myeloma CAG-00181R3 View
Fourth reconsideration Positron Emission Tomography (FDG) for Solid Tumors CAG-00181R4 View